Skip to main content
Erschienen in: Journal of Clinical Immunology 5/2007

01.09.2007

The Clinical, Immunohematological, and Molecular Study of Iranian Patients with Severe Congenital Neutropenia

verfasst von: Nima Rezaei, Mostafa Moin, Zahra Pourpak, Asghar Ramyar, Mina Izadyar, Zahra Chavoshzadeh, Roya Sherkat, Asghar Aghamohammadi, Mehdi Yeganeh, Maryam Mahmoudi, Fatemeh Mahjoub, Manuela Germeshausen, Magda Grudzien, Marshall S. Horwitz, Christoph Klein, Abolhassan Farhoudi

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Severe congenital neutropenia (SCN) is a rareE primary immunodeficiency disorder characterized by early onset recurrent infections in association with persistent severe agranulocytosis. To identify the clinical, immunohematological, and molecular characteristics of patients with SCN, 18 Iranian patients with the mean age of 8.8 ± 5.8 years were investigated in this study. All of these patients experienced severe neutropenia; the mean of absolute neutrophil count was 281.4 ± 137.7 cells/mm3. Bone marrow findings were typified by a myeloid maturation arrest at the promyelocyte–myelocyte stage in these patients. Molecular analysis revealed different mutations in the ELA-2 gene of one patient and in the HAX-1 gene of another three patients. The most common presenting complaints in these patients were superficial abscesses, oral ulcers, cutaneous infections, omphalitis, and pneumonia. During the course of illness, all patients developed mucocutaneous manifestations, and 16 cases had respiratory infections. The most commonly manifestations were abscesses, oral ulcers, pneumonia, periodontitis, otitis media, cutaneous infections, mucocutaneous candidiasis, and acute diarrhea. Three patients died because of a severe infection. Although SCN is a rare disorder, early onset of severe and recurrent infections should always raise a suspicion, which deserves further evaluation for detecting such disorder.
Literatur
1.
2.
Zurück zum Zitat Rezaei N, Farhoudi A, Ramyar A, Pourpak Z, Aghamohammadi A, Mohammadpour B, et al. Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients. J Pediatr Hematol Oncol 2005;27:351–6.PubMedCrossRef Rezaei N, Farhoudi A, Ramyar A, Pourpak Z, Aghamohammadi A, Mohammadpour B, et al. Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients. J Pediatr Hematol Oncol 2005;27:351–6.PubMedCrossRef
3.
Zurück zum Zitat Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Semin Hematol 2002;39:82–8.PubMedCrossRef Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Semin Hematol 2002;39:82–8.PubMedCrossRef
4.
Zurück zum Zitat Zeidler C, Schwinzer B, Welte K. Congenital neutropenias. Rev Clin Exp Hematol 2003;7:72–83.PubMed Zeidler C, Schwinzer B, Welte K. Congenital neutropenias. Rev Clin Exp Hematol 2003;7:72–83.PubMed
5.
Zurück zum Zitat Kostmann R. Infantile genetic agranulocytosis: a new recessive lethal disease in man. Acta Paediatr Scand 1956;45:1–78. Kostmann R. Infantile genetic agranulocytosis: a new recessive lethal disease in man. Acta Paediatr Scand 1956;45:1–78.
6.
Zurück zum Zitat Kostmann R. Infantile genetic agranulocytosis: a review with presentation of ten new cases. Acta Paediatr Scand 1975;64:362–8. Kostmann R. Infantile genetic agranulocytosis: a review with presentation of ten new cases. Acta Paediatr Scand 1975;64:362–8.
7.
Zurück zum Zitat Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology 2004;63–79. Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology 2004;63–79.
8.
Zurück zum Zitat Ancliff PJ, Gale RE, Liesner R, Hann IM, Linch DC. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 2001;98:2645–50.PubMedCrossRef Ancliff PJ, Gale RE, Liesner R, Hann IM, Linch DC. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 2001;98:2645–50.PubMedCrossRef
9.
Zurück zum Zitat Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, et al. International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee: Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 2006;117:883–96.PubMedCrossRef Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, et al. International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee: Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 2006;117:883–96.PubMedCrossRef
10.
Zurück zum Zitat Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000;96:2317–22.PubMed Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000;96:2317–22.PubMed
11.
Zurück zum Zitat Salipante S, Benson KF, Luty J, Hadavi V, Kariminejad R, Kariminejad MH, et al. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum Mutat 2007; DOI 10.1002/humu.20520. Salipante S, Benson KF, Luty J, Hadavi V, Kariminejad R, Kariminejad MH, et al. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum Mutat 2007; DOI 10.​1002/​humu.​20520.
12.
Zurück zum Zitat Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schäffer AA, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007;39:86–92.PubMedCrossRef Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schäffer AA, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007;39:86–92.PubMedCrossRef
13.
Zurück zum Zitat Zeidler C, Boxer L, Dale DC, Freedman MH, Kinsey S, Welte K. Management of Kostmann syndrome in the G-CSF era. Br J Haematol 2000;109:490–5.PubMedCrossRef Zeidler C, Boxer L, Dale DC, Freedman MH, Kinsey S, Welte K. Management of Kostmann syndrome in the G-CSF era. Br J Haematol 2000;109:490–5.PubMedCrossRef
14.
Zurück zum Zitat Carlsson G, Fasth A. Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original “Kostmann family” and a review. Acta Paediatr 2001;90:757–64.PubMedCrossRef Carlsson G, Fasth A. Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original “Kostmann family” and a review. Acta Paediatr 2001;90:757–64.PubMedCrossRef
15.
Zurück zum Zitat Bonilla MA, Gillio AP, Ruggeiro M, Kernan NA, Brochstein JA, Abboud M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320:1574–80.PubMedCrossRef Bonilla MA, Gillio AP, Ruggeiro M, Kernan NA, Brochstein JA, Abboud M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320:1574–80.PubMedCrossRef
16.
Zurück zum Zitat Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol 2006;26:519–32.PubMedCrossRef Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol 2006;26:519–32.PubMedCrossRef
17.
Zurück zum Zitat Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Movahedi M, et al. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica 2005;90:554–6.PubMed Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Movahedi M, et al. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica 2005;90:554–6.PubMed
18.
Zurück zum Zitat Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian primary immunodeficiency registry. Am J Reprod Immunol 2006;56:145–51.PubMedCrossRef Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian primary immunodeficiency registry. Am J Reprod Immunol 2006;56:145–51.PubMedCrossRef
19.
Zurück zum Zitat Suzuki Y, Demoliere C, Kitamura D, Takeshita H, Deuschle U, Watanabe T. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol 1997;158:2736–44.PubMed Suzuki Y, Demoliere C, Kitamura D, Takeshita H, Deuschle U, Watanabe T. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol 1997;158:2736–44.PubMed
20.
Zurück zum Zitat Aprikyan AA, Liles WC, Boxer LA, Dale DC. Mutant elastase in pathogenesis of cyclic and severe congenital neutropenia. J Pediatr Hematol Oncol 2002;24:784–6.PubMedCrossRef Aprikyan AA, Liles WC, Boxer LA, Dale DC. Mutant elastase in pathogenesis of cyclic and severe congenital neutropenia. J Pediatr Hematol Oncol 2002;24:784–6.PubMedCrossRef
21.
Zurück zum Zitat Cilenti L, Soundarapandian MM, Kyriazis GA, Stratico V, Singh S, Gupta S, et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 2004;279:50295–301.PubMedCrossRef Cilenti L, Soundarapandian MM, Kyriazis GA, Stratico V, Singh S, Gupta S, et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 2004;279:50295–301.PubMedCrossRef
22.
Zurück zum Zitat Carlsson G, Aprikyan AA, Tehranchi R, Dale DC, Porwit A, Hellstrom-Lindberg E, et al. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 2004;103:3355–61.PubMedCrossRef Carlsson G, Aprikyan AA, Tehranchi R, Dale DC, Porwit A, Hellstrom-Lindberg E, et al. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 2004;103:3355–61.PubMedCrossRef
23.
Zurück zum Zitat Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, et al. Severe Chronic Neutropenia International Registry: the incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006;107:4628–35.PubMedCrossRef Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, et al. Severe Chronic Neutropenia International Registry: the incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006;107:4628–35.PubMedCrossRef
24.
Zurück zum Zitat Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 1995;333:487–93.PubMedCrossRef Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 1995;333:487–93.PubMedCrossRef
Metadaten
Titel
The Clinical, Immunohematological, and Molecular Study of Iranian Patients with Severe Congenital Neutropenia
verfasst von
Nima Rezaei
Mostafa Moin
Zahra Pourpak
Asghar Ramyar
Mina Izadyar
Zahra Chavoshzadeh
Roya Sherkat
Asghar Aghamohammadi
Mehdi Yeganeh
Maryam Mahmoudi
Fatemeh Mahjoub
Manuela Germeshausen
Magda Grudzien
Marshall S. Horwitz
Christoph Klein
Abolhassan Farhoudi
Publikationsdatum
01.09.2007
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 5/2007
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-007-9106-y

Weitere Artikel der Ausgabe 5/2007

Journal of Clinical Immunology 5/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.